Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx's DNA Polymerase IIIC Inhibitor Antibiotics

PartnershipibezapolstatPositive

AI Analysis

Summary

Acurx announced a scientific partnership with Leiden University Medical Center to advance development of its DNA polymerase IIIC inhibitor antibiotics, building on prior research funded by Health-Holland in November 2025.

Importance:6/10

Sentiment:

0.60

partnershipantibioticsDNA polymerase inhibitorresearch collaboration

Related Companies

$INTI $MDCE $HIT

Read the original article

Published by PR Newswire Pharma on August 10, 2026 12:01 PM

Read Original